This story has been updated with additional comments from Datavant. Health tech company Datavant is making moves to be a bigger player in the real-world data space. The company announced Thursday that ...

You're currently following this author! Want to unfollow? Unsubscribe via the link in your email. Follow Rebecca Torrence Every time Rebecca publishes a story, you’ll get an alert straight to your ...

Data collaboration platform Datavant has partnered with life sciences commercialisation company Indegene to enhance recruitment of subjects for clinical studies. This partnership places particular ...

NEW YORK, July 11, 2025--(BUSINESS WIRE)--Datavant, a leading health data platform company, today announced the successful completion of its acquisition of Aetion, a leading real-world evidence (RWE) ...

New Mountain Capital’s Ciox Health is joining forces with Datavant to create a combined entity with the aim of empowering the secure and seamless connectivity of medical record data, sources familiar ...

NEW YORK--(BUSINESS WIRE)--Datavant, the leading health data platform company, today announced the launch of the Datavant Clinical Insights Platform, an integrated offering that empowers health plans ...

The People-Centered Research Foundation (PCRF) tapped Datavant to help it de-identify and coordinate the sharing of data across its national clinical research network covering over 60 million patients ...

Datavant, the data collaboration platform trusted for healthcare, today announced a planned partnership with athenahealth, Inc., a leading provider of network-enabled software and services for ...

Datavant and athenahealth have announced a collaboration for automating medical record requests and releases across the US. The companies will develop an offering that will merge Datavant's clinical ...

Datavant has established a fourth business vertical for itself by acquiring Ontellus, a Houston-based health records retrieval and claims intelligence company. New York City-based Datavant, which has ...

$7.0 billion transaction supported by existing investor group of New Mountain Capital, Roivant Sciences, Transformation Capital, Merck Global Health Innovation Fund, Labcorp, Cigna Ventures, Johnson & ...